This federal contract award is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,293.34 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 29, 2024, with a completion date of December 20, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/2/25, 12:46 AM